Literature DB >> 4073655

Enzyme immunoassay for surveillance of Q fever.

D E Behymer, R Ruppanner, D Brooks, J C Williams, C E Franti.   

Abstract

An enzyme-linked immunosorbent assay (ELISA) was developed to monitor antibodies against Coxiella burnetii among animal populations used in research and teaching facilities. Various antigenic components of C burnetii prepared from phase I and phase II whole cells and commercially available antigens were evaluated. A trichloroacetic acid extract was selected for routine use. There was a linear relationship between the transformed absorbance readings of the ELISA results and microagglutination (MA) titers. Comparison between positive or negative results of the MA test and ELISA gave 98.6% concordance. Using the MA test as the standard, ELISA results were 97.8% sensitive and 100% specific. The efficacy of ELISA was evaluated by testing ruminants with known histories of C burnetii infection. Antibody prevalence was 0 in 117 sheep with no history of C burnetii infection, 22% in 145 naturally infected sheep used for research, and 53% in 115 sheep used for vaccine field trials. Forty-eight percent of 120 dairy cows and 52% of 79 goats from endemically infected herds were seropositive. These results indicate that ELISA should be the test of choice for mass screening and surveillance of animals when Q fever is a suspected biohazard.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4073655

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  16 in total

1.  The use of the enzyme-linked immunosorbent assay (ELISA) in serological diagnosis of Mycoplasma bovis in dairy cattle.

Authors:  I J Uhaa; H P Riemann; M C Thurmond; C E Franti
Journal:  Vet Res Commun       Date:  1990       Impact factor: 2.459

2.  Rapid method for detection of Coxiella burnetii antibodies using high-density particle agglutination.

Authors:  S V Nguyen; H Otsuka; G Q Zhang; H To; T Yamaguchi; H Fukushi; A Noma; K Hirai
Journal:  J Clin Microbiol       Date:  1996-12       Impact factor: 5.948

3.  Prevalence of antibodies in goats in north-eastern Brazil to selected viral and bacterial agents.

Authors:  C C Brown; H J Olander; A E Castro; D E Behymer
Journal:  Trop Anim Health Prod       Date:  1989-08       Impact factor: 1.559

4.  Serosurvey of Coxiella burnetii infection in dairy goat herds in Ontario. A comparison of two methods of enzyme-linked immunosorbent assay.

Authors:  G H Lang
Journal:  Can J Vet Res       Date:  1988-01       Impact factor: 1.310

5.  Comparison of immunofluorescence with enzyme immunoassay for detection of Q fever.

Authors:  S C D'Harcourt; A B Soto; V C Burgos; D L Calero; R Martínez-Zapico
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-09       Impact factor: 3.267

6.  Enzyme-linked immunosorbent fluorescence assay and high-pressure liquid chromatography for analysis of humoral immune responses to Coxiella burnetti proteins.

Authors:  N Schmeer; H P Müller; W Baumgärtner; J Wieda; H Krauss
Journal:  J Clin Microbiol       Date:  1988-12       Impact factor: 5.948

7.  A sero-epidemiological study of Haemophilus somnus infection in dairy cattle.

Authors:  S Akhtar; T B Farver; H P Riemann
Journal:  Vet Res Commun       Date:  1997-05       Impact factor: 2.459

8.  A cross-sectional study of bluetongue virus and Mycoplasma bovis infections in dairy cattle: II. The association between a positive antibody response and reproduction performance.

Authors:  I J Uhaa; H P Riemann; M C Thurmond; C E Franti
Journal:  Vet Res Commun       Date:  1990       Impact factor: 2.459

9.  The association between antibody titres against Campylobacter fetus and reproductive efficiency in dairy cattle.

Authors:  S Akhtar; H P Riemann; M C Thurmond; C E Franti
Journal:  Vet Res Commun       Date:  1993       Impact factor: 2.459

10.  Monoclonal antibody based capture ELISA/ELIFA for detection of Coxiella burnetii in clinical specimens.

Authors:  D Thiele; M Karo; H Krauss
Journal:  Eur J Epidemiol       Date:  1992-07       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.